Tus Pharmaceutical Group Co Ltd Asset Resilience Ratio
Tus Pharmaceutical Group Co Ltd asset resilience ratio. Tus Pharmaceutical Group Co Ltd (000590) has an Asset Resilience Ratio of 4.91% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tus Pharmaceutical Group Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Tus Pharmaceutical Group Co Ltd (2002–2022)
Asset resilience ratio of Tus Pharmaceutical Group Co Ltd from 2002 to 2022. This chart shows how Tus Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Read Tus Pharmaceutical Group Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Tus Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Tus Pharmaceutical Group Co Ltd assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥43.00 Million | 4.91% |
| Total Liquid Assets | CN¥43.00 Million | 4.91% |
Asset Resilience Insights
- Limited Liquidity: Tus Pharmaceutical Group Co Ltd maintains only 4.91% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tus Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Tus Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Tus Pharmaceutical Group Co Ltd Asset Resilience Ratio by Year (2002–2022)
Tus Pharmaceutical Group Co Ltd asset resilience ratio by year from 2002 to 2022. The table below shows the annual Asset Resilience Ratio data for Tus Pharmaceutical Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 2.15% | CN¥25.11 Million ≈ $3.67 Million |
CN¥1.17 Billion ≈ $170.73 Million |
-5.61pp |
| 2021-12-31 | 7.76% | CN¥75.15 Million ≈ $11.00 Million |
CN¥967.83 Million ≈ $141.62 Million |
-14.35pp |
| 2017-12-31 | 22.12% | CN¥193.23 Million ≈ $28.28 Million |
CN¥873.74 Million ≈ $127.86 Million |
+18.69pp |
| 2014-12-31 | 3.42% | CN¥20.09 Million ≈ $2.94 Million |
CN¥586.82 Million ≈ $85.87 Million |
+3.41pp |
| 2006-12-31 | 0.02% | CN¥85.15K ≈ $12.46K |
CN¥545.36 Million ≈ $79.80 Million |
+0.00pp |
| 2005-12-31 | 0.01% | CN¥93.07K ≈ $13.62K |
CN¥664.58 Million ≈ $97.25 Million |
0.00pp |
| 2004-12-31 | 0.01% | CN¥96.04K ≈ $14.05K |
CN¥676.63 Million ≈ $99.01 Million |
0.00pp |
| 2003-12-31 | 0.02% | CN¥130.61K ≈ $19.11K |
CN¥685.16 Million ≈ $100.26 Million |
-0.01pp |
| 2002-12-31 | 0.02% | CN¥180.63K ≈ $26.43K |
CN¥724.86 Million ≈ $106.07 Million |
-- |
About Tus Pharmaceutical Group Co Ltd
Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food under the Guhan brand in China. It operates through the Pharmaceutical and Health Product Manufacturing and Sales Business, Active Pharmaceutical Ingredient (API) Manufacturing and Sales Business, and Other Business segments. The company offer… Read more